A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: gentle (98), kind (168), soft (167), weak (45)

Laparoscopic or robotic nephrectomy - Enhanced recovery programme - patient information

Description
This factsheet explains what the enhanced recovery programme is, what the programme for a laparoscopic or robotic nephrectomy involves and what
Url
/Media/UHS-website-2019/Patientinformation/Surgery/Laparoscopic-or-robotic-nephrectomy-Enhanced-recovery-programme-4048-PIL.pdf

Pre-eclampsia - patient information

Description
This factsheet explains what pre-eclampsia is, what causes it, and the steps you and your maternity team can take to
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Pre-eclampsia-4046-PIL.pdf

Oesophageal manometry test and 24-hour pH and impedance measurement test - Patients off proton pump inhibitors (PPIs) - patient information

Description
This factsheet explains what an oesophageal manometry test and a 24-hour pH and impedance measurement test are and what they
Url
/Media/UHS-website-2019/Patientinformation/Tests/Oesophageal-manometry-test-and-24-hour-pH-and-impedance-measurement-test-Patients-off-proton-pump-inhibitors-PPIs-3729-PIL.pdf

Oesophageal manometry test and 24-hour pH and impedance measurement test - Patients on proton pump inhibitors (PPIs) - patient information

Description
This factsheet explains what an oesophageal manometry test and a 24-hour pH and impedance measurement test are and what they
Url
/Media/UHS-website-2019/Patientinformation/Tests/Oesophageal-manometry-test-and-24-hour-pH-and-impedance-measurement-test-Patients-on-proton-pump-inhibitors-PPIs-3728-PIL.pdf

Radioactive iodine treatment for thyroid cancer - patient information

Description
This factsheet explains what radioactive iodine (RAI) treatment for thyroid cancer is and what the treatment involves, so you know what
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-iodine-treatment-for-thyroid-cancer-3871-PIL.pdf

Epcoritamab -Cycle 2 (Onwards)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB – Cycle 2 Onwards - (28 day) Regimen • Lymphoma-Epcoritamab – Cycle 2 Onwards - (28 da
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-2-Onwards-Ver1.pdf

Epcoritamab -Cycle 1 (Priming)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (28 day -Primin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

Tarlatamab (EAMS)

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) Tarlatamab (EAMS) Regimen • SCLC – Tarlatamab (EAM
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Tarlatamab-EAMS-Ver-1.0.pdf

AtezolizumabSC Bevacizumab Carboplatin Paclitaxel

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ATEZOLIZUMAB-SC-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AtezolizumabSC-Bevacizumab-Carboplatin-Paclitaxel-Ver1.0.pdf

Atezolizumab SC-Carboplatin(AUC5)-Etoposide (IV/PO)

Description
Chemotherapy Protocol LUNG CANCER– SMALL CELL (SCLC) ATEZOLIZUMAB-SC-CARBOPLATIN (AUC5)-ETOPOSIDE(IV/PO) Reg
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Atezolizumab-SC-CarboplatinAUC5-Etoposide-IVPO.pdf
301 to 310 of 385
Previous … 29 30 31 32 33 … Next